is Bexion Pharmaceuticals' lead compound, which is a novel S1P reduction therapy with targeted and different properties. 2. What is the focus of Bexion Pharmaceuticals?

Bexion Pharmaceuticals is poised to deliver breakthroughs in oncology and central nervous system (CNS) diseases.

What are the key milestones for Bexion Pharmaceuticals?

The key milestones for Bexion Pharmaceuticals are not provided in the given website content.

Voyager DB

Deep data on millions of local businesses, with verified decision-makers to reveal.

Contact Research

Hand-built prospect lists from human researchers, delivered in 24 hours.

People Search

Find owners and decision-makers by job title, seniority and department.

Chrome Extension

Coldlytics in your browser - prospect any business as you browse the web.

Integrations

Instantly, Smartlead, lemlist, Clay, HighLevel, plus Claude and ChatGPT over MCP.

Voyager DBDeep data on millions of local businesses, with verified decision-makers to reveal.Contact ResearchHand-built prospect lists from human researchers, delivered in 24 hours.People SearchFind owners and decision-makers by job title, seniority and department.Chrome ExtensionColdlytics in your browser - prospect any business as you browse the web.IntegrationsInstantly, Smartlead, lemlist, Clay, HighLevel, plus Claude and ChatGPT over MCP.

PricingPricing AgenciesAgencies BlogBlog

LoginLogin

Bexion Pharmaceuticals

$7.2M revenue • 40 employees • 632 Russell St, Covington, KY, 41011, United States

Last Updated Oct 1, 2026

Own this business? Claim & update this listing →

Company Overview

Company Name

Bexion Pharmaceuticals

Address

632 Russell St, Covington, KY, 41011, United States

Website

bexionpharma.com

Phone

(513) 437-3000

Approx. Annual Revenue

$7.2M

Employees

Established

2006

About Bexion Pharmaceuticals

Bexion Pharmaceuticals is a pharmaceutical company based in Covington, Kentucky, United States. The company is focused on developing breakthroughs in oncology and central nervous system (CNS) treatments, with its lead compound BXQ-350 exhibiting novel S1P reduction properties, targeted and different approaches.

Business Profile

Read from the Bexion Pharmaceuticals website on Oct 13, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed): 8/10 · Current copyright 2026; Detailed pipeline and clinical data

Biotech & Life Sciences Companies near Covington, KY

Browse all Biotech & Life Sciences companies →

Frequently Asked Questions about Bexion Pharmaceuticals

Technologies Used

Social Profiles

Key Decision Makers

Gilles Tapolsky VP, Pharmacology and Translational Sciences

Michael Gazda Senior Vice President, Research and Development

Tariq Arshad Executive Vice President, Chief Medical Officer

Ray Takigiku Founder/Scientific Consultant

Jim Beach Chief Executive Officer

Joyce LaViscount Chief Financial Officer

Jessica Cherry Clinical Trial Manager